Biktarvy (bictegravir, emtricitabina, tenofovir alafenamida)

Biktarvy is an antiviral medicine used to treat adults infected with human immunodeficiency virus 1 (HIV-1), which causes acquired immunodeficiency syndrome (AIDS), and who have no current or past evidence of resistance to inhibitors. integrase, emtricitabine, or tenofovir. It was approved by the FDA, EMA, TGA and Health Canada in 2018.